These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27070462)

  • 1. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53.
    Walia MK; Taylor S; Ho PWM; Martin TJ; Walkley CR
    Cell Death Dis; 2018 Aug; 9(9):844. PubMed ID: 30154459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.
    Ho PW; Goradia A; Russell MR; Chalk AM; Milley KM; Baker EK; Danks JA; Slavin JL; Walia M; Crimeen-Irwin B; Dickins RA; Martin TJ; Walkley CR
    Oncogene; 2015 May; 34(22):2922-33. PubMed ID: 25043296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.
    Weng Y; Shen Y; He Y; Pan X; Xu J; Jiang Y; Zhang Q; Wang S; Kong F; Zhao S; Zhou D; Zhang Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2749-2757. PubMed ID: 30093112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
    Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
    PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in osteosarcomagenesis.
    Kafchinski LA; Jones KB
    Adv Exp Med Biol; 2014; 804():119-27. PubMed ID: 24924171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
    Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
    PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria.
    Gagiannis S; Müller M; Uhlemann S; Koch A; Melino G; Krammer PH; Nawroth PP; Brune M; Schilling T
    Int J Cancer; 2009 Oct; 125(7):1551-7. PubMed ID: 19507249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local secretion of parathyroid hormone-related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition.
    Pasquini GM; Davey RA; Ho PW; Michelangeli VP; Grill V; Kaczmarczyk SJ; Zajac JD
    Bone; 2002 Nov; 31(5):598-605. PubMed ID: 12477574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.
    Kim H; Yoo S; Zhou R; Xu A; Bernitz JM; Yuan Y; Gomes AM; Daniel MG; Su J; Demicco EG; Zhu J; Moore KA; Lee DF; Lemischka IR; Schaniel C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11128-E11137. PubMed ID: 30385632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoblast-specific inactivation of p53 results in locally increased bone formation.
    Liao N; Koehne T; Tuckermann J; Triviai I; Amling M; David JP; Schinke T; Luther J
    PLoS One; 2021; 16(11):e0249894. PubMed ID: 34793446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
    Qin Y; Ye J; Zhao F; Hu S; Wang S
    Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling.
    Linder M; Glitzner E; Srivatsa S; Bakiri L; Matsuoka K; Shahrouzi P; Dumanic M; Novoszel P; Mohr T; Langer O; Wanek T; Mitterhauser M; Wagner EF; Sibilia M
    EMBO Mol Med; 2018 Nov; 10(11):. PubMed ID: 30361264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic and proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis.
    Mak IW; Turcotte RE; Ghert M
    J Bone Miner Res; 2012 Sep; 27(9):1976-91. PubMed ID: 22508574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.